The Alan B. Slifka Foundation has awarded a grant to Dr. Noah Federman, member of the UCLA Jonsson Comprehensive Cancer Center and associate professor of pediatric hematology/oncology, to further advance his research in patients with relapsed or refractory Ewing Sarcoma.
Ewing Sarcoma is a rare type of tumor that forms from a cell in bone or soft tissue and is commonly found in the bones of the legs, arms, feet, hands, chest, pelvis, spine or skull. Although rare, in the United States this aggressive cancer is the second most common primary bone cancer and is most commonly diagnosed in adolescent and young adult patients. While the outcomes for patients with newly diagnosed Ewing Sarcoma in one area or location of the body have improved substantially over the past few decades, the prognosis for patients with recurrent or metastatic bone and soft tissue cancers remains unchanged with survival being the exception rather than the rule.
Federman hopes this research will lead to better targeted therapies and improve the overall survival and quality of life for pediatric, adolescent and young adult cancer patients.
For more information, visit the UCLA Jonsson Comprehensive Cancer Center.
